| Reassessment of stiripentol pharmacokinetics in healthy adult volunteers S Peigné, E Rey, ME Le Guern, O Dulac, C Chiron, G Pons, V Jullien Epilepsy research 108 (5), 909-916, 2014 | 27 | 2014 |
| Population pharmacokinetics of stiripentol in paediatric patients with Dravet syndrome treated with stiripentol, valproate and clobazam combination therapy S Peigné, S Chhun, M Tod, E Rey, C Rodrigues, C Chiron, G Pons, ... Clinical Pharmacokinetics 57 (6), 739-748, 2018 | 23 | 2018 |
| Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment S Peigné, F Bouzom, K Brendel, C Gesson, S Fouliard, M Chenel Journal of pharmacokinetics and pharmacodynamics 43 (1), 13-27, 2016 | 15 | 2016 |
| Model-based approaches for ivabradine development in paediatric population, part II: PK and PK/PD assessment S Peigné, S Fouliard, S Decourcelle, M Chenel Journal of pharmacokinetics and pharmacodynamics 43 (1), 29-43, 2016 | 10 | 2016 |
| Application of item response theory to model disease progression and agomelatine effect in patients with major depressive disorder M Cerou, S Peigné, E Comets, M Chenel The AAPS journal 22 (1), 1-13, 2020 | 7 | 2020 |
| Population pharmacokinetic study in healthy volunteers treated with 3 single doses of stiripentol (500, 1000, 2000 mg) S Chhun, S Peigne, E Rey, G Pons, V Jullien FUNDAMENTAL & CLINICAL PHARMACOLOGY 23, 24-25, 2009 | 1 | 2009 |
| Etude de la pharmacocinétique du stiripentol chez le volontaire sain par une approche de population S Peigné | | 2010 |
| Paediatric Pharmacokinetic methodologies: Evaluation and comparison Sophie Peigné1, Charlotte Gesson1, Vincent Jullien2, 3 and Marylore Chenel1 1Department of Clinical … S Peigne | | |
| How modelling & simulation supported the drug development in children for a drug S S Peigné, S Fouliard, M Chenel | | |
| Optimal design in the analysis of a clinical study in paediatric population S Peigné, S Fouliard, A Tessier, M Chenel | | |
